Rolon v. Boehringer Ingelheim Pharmaceuticals, Inc.
Rafael Rolon |
Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation, Glaxosmithkline Holdings (Americas), Inc., Pfizer, Inc., Sanofi-Aventis U.S. LLC, Sanofi US Services Inc. and GlaxoSmithKline LLC |
23-883 |
June 13, 2023 |
U.S. Court of Appeals, Second Circuit |
Torts |
Docket Report
This docket was last retrieved on July 18, 2023. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 86 CURED DEFECTIVE JOINT APPENDIX, volumes 1-5, [ # 79 ], [ # 80 ], [ # 81 ], [ # 82 ], [ # 83 ], on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, FILED.[3543230] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 02:46 PM] |
Filing 85 CURED DEFECTIVE BRIEF & SPECIAL APPENDIX, [ # 78 ], on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, FILED.[3543227] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 02:44 PM] |
Filing 84 MOTION ORDER, granting motion to adjourn oral argument [ # 75 ] filed by Appellant Sanofi-Aventis U.S. LLC and Sanofi US Services Inc. in 23-877, FILED. [3543211][84] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 02:35 PM] |
Filing 83 JOINT APPENDIX, volume 5 of 5, (pp. 1036-1307), on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/18/2023 by CM/ECF.[3543205] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 02:30 PM] |
Filing 82 JOINT APPENDIX, volume 4 of 5, (pp. 780-1035), on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/18/2023 by CM/ECF.[3543199] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 02:28 PM] |
Filing 81 JOINT APPENDIX, volume 3 of 5, (pp. 530-779), on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/18/2023 by CM/ECF.[3543196] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 02:24 PM] |
Filing 80 JOINT APPENDIX, volume 2 of 5, (pp. 261-529), on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/18/2023 by CM/ECF.[3543192] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 02:21 PM] |
Filing 79 JOINT APPENDIX, volume 1 of 5, (pp. 1-260), on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/18/2023 by CM/ECF.[3543189] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 02:19 PM] |
Filing 78 BRIEF & SPECIAL APPENDIX, on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/18/2023 by CM/ECF. [3543185] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 02:15 PM] |
Filing 76 CURED DEFECTIVE MOTION, TO ADJOURN ORAL ARGUMENT, [ # 75 ], on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, FILED.[3543083] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 12:56 PM] |
Filing 75 MOTION, to adjourn oral argument, on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/18/2023 by CM/ECF. [3543073] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 12:52 PM] |
Filing 71 DEFECTIVE DOCUMENT, Joint Appendix, volumes 1-5, [62], [63], [64], [65], [66], on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, FILED.[3542873] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 09:17 AM] |
Filing 70 DEFECTIVE DOCUMENT, Brief & Special Appendix, [61], on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, FILED.[3542867] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 09:06 AM] |
Filing 69 DEFECTIVE DOCUMENT, MOTION, to adjourn oral argument, [67], on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, FILED.[3542842] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 08:43 AM] |
Filing 67 MOTION, to adjourn oral argument, on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/17/2023 by CM/ECF. [3542754] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885]--[Edited 07/18/2023 by RW] [Entered: 07/17/2023 08:06 PM] |
Filing 66 JOINT APPENDIX, volume 5 of 5, (pp. 1036-1307), on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/17/2023 by CM/ECF.[3542747] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/17/2023 07:19 PM] |
Filing 65 JOINT APPENDIX, volume 4 of 5, (pp. 780-1035), on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/17/2023 by CM/ECF.[3542746] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/17/2023 07:15 PM] |
Filing 64 JOINT APPENDIX, volume 3 of 5, (pp. 530-779), on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/17/2023 by CM/ECF.[3542745] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/17/2023 07:13 PM] |
Filing 63 JOINT APPENDIX, volume 2 of 5, (pp. 261-529), on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/17/2023 by CM/ECF.[3542744] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/17/2023 07:10 PM] |
Filing 62 JOINT APPENDIX, volume 1 of 5, (pp. 1-260), on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/17/2023 by CM/ECF.[3542743] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/17/2023 07:08 PM] |
Filing 61 BRIEF & SPECIAL APPENDIX, on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/17/2023 by CM/ECF. [3542742] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/17/2023 07:05 PM] |
Filing 58 NEW CASE MANAGER, Ronald Willoughby, ASSIGNED.[3541402] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/14/2023 08:45 AM] |
Filing 52 CURED DEFECTIVE Notice of Appearance as Additional Counsel [ # 44 ] , on behalf of Appellee Rafael Rolon, FILED.[3539004] [23-883] [Entered: 07/09/2023 05:59 PM] |
Filing 51 CURED DEFECTIVE Notice of Appearance as Additional Counsel [ # 43 ], on behalf of Appellee Rafael Rolon, FILED.[3539003] [23-883] [Entered: 07/09/2023 05:58 PM] |
Filing 50 ATTORNEY, Robert A. Izard Jr. for Rafael Rolon, in case 23-883, [ # 43 ], ADDED.[3539002] [23-883] [Entered: 07/09/2023 05:57 PM] |
Filing 49 ATTORNEY, Craig Archer Raabe for Rafael Rolon, in case 23-883, [ # 46 ], ADDED.[3539001] [23-883] [Entered: 07/09/2023 05:56 PM] |
Filing 48 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellee Rafael Rolon, FILED. Service date 07/05/2023 by CM/ECF. [3537363] [23-883] [Entered: 07/05/2023 04:11 PM] |
Filing 46 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellee Rafael Rolon, FILED. Service date 07/05/2023 by CM/ECF. [3537256] [23-883] [Entered: 07/05/2023 02:58 PM] |
Filing 44 DEFECTIVE DOCUMENT, Notice of Appearance as Additional Counsel, [36], on behalf of Appellee Jerome Jay Berkowitz, Mary Cassidy, John Corwin, Armando Ramos, Rafael Rolon, Roderick Sullivan, Thomas Vazzano and Anne Yost in 23-877, Appellee Jerome Jay Berkowitz in 23-878, Appellee Armando Ramos in 23-879, Appellee Mary Cassidy in 23-880, Appellee John Corwin in 23-881, Appellee Thomas Vazzano in 23-882, Appellee Rafael Rolon in 23-883, Appellee Roderick Sullivan in 23-884, Appellee Anne Yost in 23-885, FILED.[3537032] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/05/2023 11:21 AM] |
Filing 43 DEFECTIVE DOCUMENT, Notice of Appearance as Additional Counsel, [34], on behalf of Appellee Beth Bacher, Jerome Jay Berkowitz, Mary Cassidy, John Corwin, Armando Ramos, Rafael Rolon, Roderick Sullivan, Thomas Vazzano and Anne Yost in 23-877, FILED.[3537005] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/05/2023 11:09 AM] |
Filing 40 CURED DEFECTIVE Form C [ # 28 ], [ # 39 ], on behalf of Appellant Pfizer, Inc., FILED.[3535780] [23-883] [Entered: 06/29/2023 02:22 PM] |
Filing 39 FORM C, on behalf of Appellant Pfizer, Inc., FILED. Service date 06/29/2023 by CM/ECF.[3535731] [23-883] [Entered: 06/29/2023 01:49 PM] |
Filing 38 FORM D, on behalf of Appellant Glaxosmithkline Holdings (Americas), Inc. and GlaxoSmithKline LLC, FILED. Service date 06/29/2023 by CM/ECF.[3535625] [23-883] [Entered: 06/29/2023 12:08 PM] |
Filing 37 FORM C, on behalf of Appellant Glaxosmithkline Holdings (Americas), Inc. and GlaxoSmithKline LLC, FILED. Service date 06/29/2023 by CM/ECF.[3535623] [23-883] [Entered: 06/29/2023 12:06 PM] |
Filing 36 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellee Beth Bacher, Jerome Jay Berkowitz, Mary Cassidy, John Corwin, Armando Ramos, Rafael Rolon, Roderick Sullivan, Thomas Vazzano and Anne Yost in 23-877, Appellee Jerome Jay Berkowitz in 23-878, Appellee Armando Ramos in 23-879, Appellee Mary Cassidy in 23-880, Appellee John Corwin in 23-881, Appellee Thomas Vazzano in 23-882, Appellee Rafael Rolon in 23-883, Appellee Roderick Sullivan in 23-884, Appellee Anne Yost in 23-885, FILED. Service date 06/29/2023 by CM/ECF. [3535620] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 06/29/2023 12:04 PM] |
Filing 35 ACKNOWLEDGMENT AND NOTICE OF APPEARANCE, on behalf of Appellant Glaxosmithkline Holdings (Americas), Inc. and GlaxoSmithKline LLC, FILED. Service date 06/29/2023 by CM/ECF.[3535618] [23-883] [Entered: 06/29/2023 12:01 PM] |
Filing 34 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellee Beth Bacher, Jerome Jay Berkowitz, Mary Cassidy, John Corwin, Armando Ramos, Rafael Rolon, Roderick Sullivan, Thomas Vazzano and Anne Yost in 23-877, Appellee Jerome Jay Berkowitz in 23-878, Appellee Armando Ramos in 23-879, Appellee Mary Cassidy in 23-880, Appellee John Corwin in 23-881, Appellee Thomas Vazzano in 23-882, Appellee Rafael Rolon in 23-883, Appellee Roderick Sullivan in 23-884, Appellee Anne Yost in 23-885, FILED. Service date 06/29/2023 by CM/ECF. [3535610] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 06/29/2023 11:49 AM] |
Filing 32 ATTORNEY, Joseph W. Martini for Sanofi US Services Inc. Sanofi-Aventis U.S. LLC, in case 23-883, [ # 5 ], ADDED.[3535490] [23-883] [Entered: 06/29/2023 09:40 AM] |
Filing 31 ATTORNEY, Lauren R. Greenspoon for Glaxosmithkline Holdings (Americas), Inc. GlaxoSmithKline LLC, in case 23-883, [ # 10 ], ADDED.[3535485] [23-883] [Entered: 06/29/2023 09:37 AM] |
Filing 30 ATTORNEY, Anand Agneshwar for Sanofi US Services Inc. Sanofi-Aventis U.S. LLC, in case 23-883, [ # 11 ], ADDED.[3535479] [23-883] [Entered: 06/29/2023 09:35 AM] |
Filing 29 ATTORNEY, Daniel S. Pariser for Sanofi US Services Inc. Sanofi-Aventis U.S. LLC, in case 23-883, [ # 15 ], ADDED.[3535472] [23-883] [Entered: 06/29/2023 09:31 AM] |
Filing 28 DEFECTIVE DOCUMENT, Form C, [ # 17 ], on behalf of Appellant Pfizer, Inc., FILED.[3535454] [23-883] [Entered: 06/29/2023 09:21 AM] |
Filing 27 CURED DEFECTIVE NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL [ # 26 ], [ # 22 ], on behalf of Appellant GlaxoSmithKline LLC and Glaxosmithkline Holdings (Americas), Inc., FILED.[3535446] [23-883] [Entered: 06/29/2023 09:15 AM] |
Filing 26 DEFECTIVE DOCUMENT, NOTICE OF APPEARANCE AS SUBSTITUTE COUNSEL, [ # 18 ], on behalf of Appellant GlaxoSmithKline LLC and Glaxosmithkline Holdings (Americas), Inc., FILED.[3535437] [23-883] [Entered: 06/29/2023 09:09 AM] |
Filing 25 ATTORNEY, James I. Glasser for Pfizer, Inc., in case 23-883, [ # 20 ], ADDED.[3535425] [23-883] [Entered: 06/29/2023 09:00 AM] |
Filing 24 ATTORNEY, Jaime Ashley Welsh for Boehringer Ingelheim Corporation Boehringer Ingelheim USA Corporation Boehringer Ingelheim Pharmaceuticals, Inc., in case 23-883, [ # 21 ], ADDED.[3535418] [23-883] [Entered: 06/29/2023 08:56 AM] |
Filing 23 ATTORNEY, Lindsey Cohan for Glaxosmithkline Holdings (Americas), Inc. GlaxoSmithKline LLC, in case 23-883, [ # 22 ], ADDED.[3535417] [23-883] [Entered: 06/29/2023 08:54 AM] |
Filing 33 ELECTRONIC INDEX, in lieu of record, FILED.[3535501] [23-883] [Entered: 06/29/2023 09:49 AM] |
Filing 22 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellant Glaxosmithkline Holdings (Americas), Inc. and GlaxoSmithKline LLC, FILED. Service date 06/28/2023 by CM/ECF. [3535264] [23-883] [Entered: 06/28/2023 04:52 PM] |
Filing 21 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellant Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim USA Corporation, FILED. Service date 06/28/2023 by CM/ECF. [3535108] [23-883] [Entered: 06/28/2023 03:16 PM] |
Filing 20 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellant Pfizer, Inc., FILED. Service date 06/27/2023 by CM/ECF. [3534579] [23-883] [Entered: 06/27/2023 05:58 PM] |
Filing 19 FORM D, on behalf of Appellant Pfizer, Inc., FILED. Service date 06/27/2023 by CM/ECF.[3534578] [23-883] [Entered: 06/27/2023 05:56 PM] |
Filing 18 NOTICE OF APPEARANCE AS SUBSTITUTE COUNSEL, on behalf of Appellant Glaxosmithkline Holdings (Americas), Inc. and GlaxoSmithKline LLC, FILED. Service date 06/27/2023 by CM/ECF. [3534577] [23-883] [Entered: 06/27/2023 05:55 PM] |
Filing 17 FORM C, on behalf of Appellant Pfizer, Inc., FILED. Service date 06/27/2023 by CM/ECF.[3534576] [23-883] [Entered: 06/27/2023 05:55 PM] |
Filing 16 ACKNOWLEDGMENT AND NOTICE OF APPEARANCE, on behalf of Appellant Pfizer, Inc., FILED. Service date 06/27/2023 by CM/ECF.[3534575] [23-883] [Entered: 06/27/2023 05:52 PM] |
Filing 15 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC, FILED. Service date 06/27/2023 by CM/ECF. [3534532] [23-883] [Entered: 06/27/2023 04:54 PM] |
Filing 14 FORM D, on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC, FILED. Service date 06/27/2023 by CM/ECF.[3534531] [23-883] [Entered: 06/27/2023 04:53 PM] |
Filing 13 FORM C, on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC, FILED. Service date 06/27/2023 by CM/ECF.[3534528] [23-883] [Entered: 06/27/2023 04:52 PM] |
Filing 12 ACKNOWLEDGMENT AND NOTICE OF APPEARANCE, on behalf of Appellee Rafael Rolon, FILED. Service date 06/27/2023 by CM/ECF, email.[3534522] [23-883] [Entered: 06/27/2023 04:50 PM] |
Filing 11 NOTICE OF APPEARANCE AS SUBSTITUTE COUNSEL, on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC, FILED. Service date 06/27/2023 by CM/ECF. [3534518] [23-883] [Entered: 06/27/2023 04:49 PM] |
Filing 10 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellant Glaxosmithkline Holdings (Americas), Inc. and GlaxoSmithKline LLC, FILED. Service date 06/27/2023 by CM/ECF. [3534452] [23-883] [Entered: 06/27/2023 04:10 PM] |
Filing 9 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellant Glaxosmithkline Holdings (Americas), Inc. and GlaxoSmithKline LLC, FILED. Service date 06/27/2023 by CM/ECF. [3534415] [23-883] [Entered: 06/27/2023 03:45 PM] |
Filing 8 FORM D, on behalf of Appellant Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim USA Corporation, FILED. Service date 06/27/2023 by CM/ECF.[3534315] [23-883] [Entered: 06/27/2023 02:10 PM] |
Filing 7 FORM C, on behalf of Appellant Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim USA Corporation, FILED. Service date 06/27/2023 by CM/ECF.[3534314] [23-883] [Entered: 06/27/2023 02:10 PM] |
Filing 6 ACKNOWLEDGMENT AND NOTICE OF APPEARANCE, on behalf of Appellant Boehringer Ingelheim Corporation and Boehringer Ingelheim USA Corporation, FILED. Service date 06/27/2023 by CM/ECF.[3534312] [23-883] [Entered: 06/27/2023 02:09 PM] |
Filing 5 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC, FILED. Service date 06/27/2023 by CM/ECF. [3534254] [23-883] [Entered: 06/27/2023 01:38 PM] |
Filing 4 CASE CALENDARING, for the week of 09/18/2023, A, PROPOSED.[3531137] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 06/20/2023 01:10 PM] |
Filing 3 ORDER, dated 06/16/2023, setting Appellant's brief due date as July 17, 2023 and Appellees' brief due date as August 17, 2023. The reply brief is due by August 28, 2023. The Clerk is directed to set the appeal for argument as early as the week of September 18, 2023., FILED.[3530582] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 06/16/2023 04:28 PM] |
Filing 2 DISTRICT COURT ORDER, entered in the district court as docket entry dated 01/17/2023, RECEIVED.[3528613] [23-883] [Entered: 06/13/2023 02:20 PM] |
Filing 1 NOTICE OF CIVIL APPEAL, with district court docket, on behalf of Appellant Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation, GlaxoSmithKline LLC, Glaxosmithkline Holdings (Americas), Inc., Pfizer, Inc., Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC, FILED. [3528609] [23-883] [Entered: 06/13/2023 02:16 PM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.